NDC Labeler Samsung Biologics, Ltd
Samsung Biologics, Ltd labeler's code is 71124. The labeler has 30 products that have an assigned National Drug Code.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Product Type | Status |
|---|---|---|---|---|---|---|
| 71124-0001 | Ipilimumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0002 | Nivolumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0003 | Rituximab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0004 | Infliximab | Injection, Powder, Lyophilized, For Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0005 | Telavancin | Injection, Powder, Lyophilized, For Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0007 | Daratumumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0008 | Infliximab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0009 | Emicizumab | Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0010 | Emicizumab | Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0011 | Emicizumab | Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0012 | Emicizumab | Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0013 | Tildrakizumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0014 | Thrombin Alfa | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0015 | Sacituzumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0016 | Perflutren | Injection, Suspension | Drug For Further Processing | UNFINISHED | ||
| 71124-0017 | Bamlanivimab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0018 | Etesevimab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0019 | Tocilizumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0020 | Ipilimumab | Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0021 | Ipilimumab | Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0022 | Ipilimumab | Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0023 | Adalimumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0024 | Ibalizumab | Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0025 | Belimumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0026 | Ublituximab | Solution | Drug For Further Processing | UNFINISHED | ||
| 71124-0027 | Adalimumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0028 | Lebrikizumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0028 | Lebrikizumab | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0029 | Bevacizumab-bvzr | Liquid | Bulk Ingredient | UNFINISHED | ||
| 71124-0030 | Durvalumab | Liquid | Bulk Ingredient | UNFINISHED |